FLUTRIMAZOLE structure
|
Common Name | FLUTRIMAZOLE | ||
---|---|---|---|---|
CAS Number | 119006-77-8 | Molecular Weight | 346.373 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 457.1±40.0 °C at 760 mmHg | |
Molecular Formula | C22H16F2N2 | Melting Point | 161-166ºC | |
MSDS | N/A | Flash Point | 230.3±27.3 °C |
Use of FLUTRIMAZOLEFlutrimazole is an imidazole antifungal with dual anti-inflammatory and antifungal activity. Flutrimazole shows scarce transdermal penetration. Flutrimazole has the advantageous in the research of topical fungal infections with an inflammatory component[1]. |
Name | flutrimazole |
---|---|
Synonym | More Synonyms |
Description | Flutrimazole is an imidazole antifungal with dual anti-inflammatory and antifungal activity. Flutrimazole shows scarce transdermal penetration. Flutrimazole has the advantageous in the research of topical fungal infections with an inflammatory component[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 457.1±40.0 °C at 760 mmHg |
Melting Point | 161-166ºC |
Molecular Formula | C22H16F2N2 |
Molecular Weight | 346.373 |
Flash Point | 230.3±27.3 °C |
Exact Mass | 346.128143 |
PSA | 17.82000 |
LogP | 4.95 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.590 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~% FLUTRIMAZOLE CAS#:119006-77-8 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 42, # 6 p. 832 - 835 |
~% FLUTRIMAZOLE CAS#:119006-77-8 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 42, # 6 p. 832 - 835 |
~% FLUTRIMAZOLE CAS#:119006-77-8 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 42, # 6 p. 832 - 835 |
~% FLUTRIMAZOLE CAS#:119006-77-8 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 42, # 6 p. 832 - 835 |
Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-release cream (1, 2 and 4%) with placebo site-release vaginal cream.
Mycoses 43(9-10) , 355-65, (2000) A double-blind randomized comparative phase II study of flutrimazole site-release vaginal cream (1, 2 and 4%) with placebo site-release vaginal cream was undertaken in patients with acute vulvovaginal... |
|
Efficacy of flutrimazole 1% powder in the treatment of tinea pedis.
Mycoses 46(3-4) , 126-31, (2003) The aim of the study was to compare the efficacy and tolerability of flutrimazole 1% powder vs. bifonazole 1% powder in treating tinea pedis. A multicentre, double blind, randomized, parallel and comp... |
|
Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial.
Mycoses 53(6) , 522-9, (2010) Fluconazole, which is a drug of the azole family, is safely used in systemic treatment of oral and intravenous injection, but it is difficult to use fluconazole as a topical application because of its... |
Flutrimazolum |
1-[(2-Fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-Imidazol |
Flutrimazole (INN) |
FLUTRIMAZOLE |
1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1H-imidazole |
Micetal |
Flutrimazolum [INN-Latin] |
Flutrimazol [INN-Spanish] |
1-[(2-fluorophenyl)-(4-fluorophenyl)-phenylmethyl]imidazole |
MFCD00865591 |
Flutrimazol |
1-[(2-Fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole |
1-[o-Fluoro-a-(p-fluorophenyl)-a-phenylbenzyl]imidazole |
1H-Imidazole, 1-[(2-fluorophenyl)(4-fluorophenyl)phenylmethyl]- |
UR-4056 |